The law firm representing the wife of the late AFL player Shane Tuck in a class against the Australian Football League on behalf of players who allegedly suffered brain injuries is seeking court approval to discontinue the case for lack of litigation funding.
Insurer JLT Risk Solutions won’t pay any compensation to resolve a long-running class action on behalf of Victorian councils, after defeating a similar class action in New South Wales.
The first healthcare provider to be found liable in one of several underpayments class actions by junior doctors is challenging a ruling that found permission to work overtime hours did not have to be expressly given.
Seven Network and chairman Kerry Stokes can challenge a ruling allowing Fairfax to access thousands of “deeply personal” emails sent to and from former soldier Ben Roberts-Smith during his defamation case.
The Australian arm of coffee giant Starbucks has backpaid part-time workers across 52 stores $4.5 million, after discovering it failed to pay proper overtime rates.
The Australian Competition and Consumer Commission will not sign off on Transurban’s plan to acquire a majority stake in fellow toll road operator Horizon Roads, finding the deal would likely reduce competition for toll road concessions in Victoria.
A judge has approved a common fund order awarding $6.88 million to the funder behind a class action against Fonterra that settled for $25 million, opting not to wait for a much-anticipated appeals court ruling on the power to make CFOs at settlement.
The competition regulator has again raised concerns about how a planned acquisition by Dan Murphy’s owner Endeavour Group could affect competition in a local market for takeaway liquor. In a statement of issues released Thursday, the Australian Competition and Consumer Commission expressed preliminary worries that Endeavour’s purchase of the Rye Hotel on Victoria’s Mornington Peninsula…
A judge has rejected the energy regulator’s claims that the owner of the Pelican Point power station in Adelaide failed to disclose its complete generator capacity to the energy market operator for months, contributing to rolling blackouts during a 2017 heatwave.
Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.